New sweat test device for cystic fibrosis monitoring
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study tests a new, portable device that measures the amount of salt in your sweat to help monitor how well your CF treatment is working. It is a simple, non-invasive test that could make monitoring easier than traditional methods.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 0 and 90 years old
- You have a confirmed diagnosis of cystic fibrosis, either through a genetic test or a newborn screening result
- You are willing to sign a consent form (or have a guardian sign for you)
- You do not have skin conditions such as eczema or psoriasis on your forearms that could interfere with the test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new treatments for cystic fibrosis in people who cannot take or choose not to take current CFTR modulators. It aims to find better options for managing CF.
This early study tests an individualized approach (“theratyping”) to match your cystic fibrosis (CF) to the CFTR medicine that may work best for your specific genetic change. It may help find a more tailored treatment plan and see how your body responds, while using medicines that are already approved for some people with CF.
This study collects cells from people with cystic fibrosis (CF) caused by rare CFTR gene changes. The goal is to build a cell bank for future research, which may help scientists develop better tests and treatments for rare CF types.
This trial tests a new device that measures how your sweat glands react to a common asthma medication. It aims to better classify people with cystic fibrosis or related diseases, and also includes healthy volunteers and carriers.
This trial tests a new skin sensor that measures sweat to help diagnose cystic fibrosis. It compares results from people with CF and healthy volunteers to see if the device works accurately.
This trial tests how well cystic fibrosis (CF) medicine works for you using an “n-of-1” approach, meaning you try treatments in a structured, repeated way to see what helps you most. It may help your care team choose the best option for your specific CF genetics and health status.
Hear when a new Cystic Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.